John F. Bauer
About
In The Last Decade
John F. Bauer
20 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Materials Chemistry 954
- Physical and Theoretical Chemistry 593
- Spectroscopy 391
- Pharmaceutical Science 291
- Organic Chemistry 225
Countries citing papers authored by John F. Bauer
This map shows the geographic impact of John F. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Bauer more than expected).
Fields of papers citing papers by John F. Bauer
This network shows the impact of papers produced by John F. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Bauer. The network helps show where John F. Bauer may publish in the future.
Co-authorship network of co-authors of John F. Bauer
This figure shows the co-authorship network connecting the top 25 collaborators of John F. Bauer. A scholar is included among the top collaborators of John F. Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Bauer. John F. Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Pharmaceutical Solids: Size, Shape, and Surface Area | 4 |
| 2 | Polymorphism—A Critical Consideration in Pharmaceutical Development, Manufacturing, and Stability | 19 |
| 3 | 9 | |
| 4 | 15 | |
| 5 | Ritonavir: An Extraordinary Example of Conformational Polymorphism breakdown → | 801 |
| 6 | 11 | |
| 7 | Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development breakdown → | 506 |
| 8 | 24 | |
| 9 | [Demonstration of zearalenone metabolites in bile of breeding sows with fertility disturbances]. | 3 |
| 10 | 2 | |
| 11 | 13 | |
| 12 | 13 | |
| 13 | 15 | |
| 14 | 9 | |
| 15 | 6 | |
| 16 | 16 | |
| 17 | 19 | |
| 18 | 9 | |
| 19 | 27 | |
| 20 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.